Literature DB >> 9409395

Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey.

K Wakai1, A Tamakoshi, K Ikezaki, M Fukui, T Kawamura, R Aoki, M Kojima, Y Lin, Y Ohno.   

Abstract

To estimate an annual number of patients treated for Moyamoya disease in Japan and to describe the clinico-epidemiological features, a nationwide epidemiological survey was conducted in 1995. The study consisted of two questionnaires, which were distributed to departments randomly selected, of neurosurgery, neurology and pediatrics in hospitals throughout Japan. The first questionnaire inquired the number of the patients treated in 1994 and the second one detailed clinico-epidemiological information of each patient reported. Following major epidemiological findings emerged from the study: (a) The total annual number of patients treated for Moyamoya disease was estimated as 3900 (95% confidence interval (CI) 3500-4400) in Japan 1994, with the prevalence and incidence rates of 3.16 and 0.35 per 100,000 population, respectively; (b) the sex ratio (females to males) of the patients was 1.8; (c) the peak of age distribution of the patients was observed in 10-14 years old and a smaller peak in their forties; (d) the age at onset was under 10 years old in 47.8% of the patients, but some had developed the disease at the age of 25-49 years; (e) family history of Moyamoya disease was found in 10.0% of the patients; and (f) about 75% of the patients had normal activity of daily life or working ability even before treatment. The present findings were quite comparable with those obtained in the previous nationwide epidemiological survey in 1990.

Entities:  

Mesh:

Year:  1997        PMID: 9409395     DOI: 10.1016/s0303-8467(97)00031-0

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  75 in total

1.  Comparative analysis of serum proteomes of moyamoya disease and normal controls.

Authors:  Eun-Jeong Koh; Han-Na Kim; Tian-Ze Ma; Ha-Young Choi; Yong-Geun Kwak
Journal:  J Korean Neurosurg Soc       Date:  2010-07-31

2.  Adult unilateral moyamoya disease with familial occurrence in two definite cases: a case report and review of the literature.

Authors:  Noboru Kusaka; Takashi Tamiya; Yoshiaki Adachi; Shinji Katayama; Shimpei Namba; Koji Tokunaga; Kenji Sugiu; Isao Date; Takashi Ohmoto
Journal:  Neurosurg Rev       Date:  2005-07-15       Impact factor: 3.042

3.  Surgical Revascularization in North American Adults with Moyamoya Phenomenon: Long-Term Angiographic Follow-up.

Authors:  Eric J Arias; Gavin P Dunn; Chad W Washington; Colin P Derdeyn; Michael R Chicoine; Robert L Grubb; Christopher J Moran; DeWitte T Cross; Ralph G Dacey; Gregory J Zipfel
Journal:  J Stroke Cerebrovasc Dis       Date:  2015-05-09       Impact factor: 2.136

4.  Moyamoya complicated by thrombotic cerebrovascular accident in a Caucasian woman with collagenous colitis.

Authors:  Manshi Valluri; Hossein Akhondi; Mark Hyndman
Journal:  Neurol Sci       Date:  2018-08-09       Impact factor: 3.307

5.  Moyamoya disease - a vasculopahty and an uncommon cause of recurrent cerebrovascular accidents.

Authors:  Yasmin S Hamirani; Mohammad Valikhani; Allison Sweney; Hafsa Khan; Mohammad Pathan
Journal:  J Radiol Case Rep       Date:  2008-09-01

6.  Cerebrovascular collaterals correlate with disease severity in adult North American patients with Moyamoya disease.

Authors:  M K Strother; M D Anderson; R J Singer; L Du; R D Moore; Y Shyr; T R Ladner; D Arteaga; M A Day; P F Clemmons; M J Donahue
Journal:  AJNR Am J Neuroradiol       Date:  2014-03-20       Impact factor: 3.825

7.  Missing relationship of moyamoya and persistent primitive artery in Europeans. Another distinctive feature or artifact?

Authors:  Holger Wenz; Ralf Wenz; Alex Förster; Johann Fontana; Hans Ulrich Kerl; Christoph Groden; Johann Scharf
Journal:  Surg Radiol Anat       Date:  2015-03-08       Impact factor: 1.246

Review 8.  Pediatric moyamoya disease: clinical profile, literature review and sixteen year experience from a tertiary care teaching institute.

Authors:  Pratibha Singhi; Anita Choudhary; Niranjan Khandelwal
Journal:  Indian J Pediatr       Date:  2013-03-24       Impact factor: 1.967

9.  Identification of novel biomarker candidates by proteomic analysis of cerebrospinal fluid from patients with moyamoya disease using SELDI-TOF-MS.

Authors:  Yoshio Araki; Kazuhiro Yoshikawa; Sho Okamoto; Masaki Sumitomo; Mikio Maruwaka; Toshihiko Wakabayashi
Journal:  BMC Neurol       Date:  2010-11-08       Impact factor: 2.474

Review 10.  [Juvenile stroke - what is important?]

Authors:  M Fischer; B Eckert; J Röther
Journal:  Nervenarzt       Date:  2018-02       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.